Anne Wojcicki

Anne Wojcicki is an investor, biologist, philanthropist, and the cofounder and CEO of 23andMe. She also serves on the boards of 23andMeand Breakthrough Prize, cofounded the Brin Wojcicki Foundation, and founded the Anne Wojcicki Foundation.

Wojcicki cofounded 23andMe in 2006 with Linda Avey and Paul Cusenza. Before founding 23andMe, Wojcicki spent ten years on Wall Street investing in healthcare. During her time there, she felt frustrated by a system built around monetizing illness instead of incentivizing prevention. She wanted to build a business that would help people prevent illness rather than profit from it.

Additionally, getting access to and understanding her own genetic information had always been one of her ambitions. Wojcicki started 23andMe with the hope to empower others with access to their own genetic information and to create a way to generate more personalized information so commercial and academic researchers could better understand and develop new drugs and diagnostics.

Anne Wojcicki is an investor, biologist, philanthropist, and the co-founder cofounder and CEO of 23andMe. She also serves on the boardboards of 23andMe, the board of23andMeand Breakthrough Prize, cofounded the Brin Wojcicki Foundation, and founded the Anne Wojcicki Foundation.

In 2021, Wojcicki was ranked #25 inon Forbes' America's Self-Made Women and #90 inon the Forbes' Power Women, and her net worth was estimated at $1.1 billion. Additionally, she is the younger sister of Susan Wojcicki, CEO of YouTube, and was married to Sergey Brin, the co-foundercofounder of Google.

Wojcicki co-foundedcofounded 23andMe in 2006 with Linda Avey and Paul Cusenza. Before founding 23andMe, Wojcicki spent ten years on Wall Street investing in healthcare. During her time there, she felt frustrated by a system built around monetizing illness instead of incentivizing prevention. She wanted to build a business that would help people prevent illness rather than profit from it.

Additionally, getting access to and understanding her own genetic information had always been one of her ambitions. Wojcicki started 23andMe with the hope to empower others with access to their own genetic information and to create a way to generate more personalized information so that commercial and academic researchers could better understand and develop new drugs and diagnostics.

23andMe provides the only personal genetic test with FDA authorization to deliver health information directly to consumers. The company has brought personalized medicine directly to millions of consumerspeople, and Wojcicki is considered a pioneer in the direct-to-consumer DNA testing industry.

Wojcicki earned a BS in Biology biology from Yale University in 1996. She also worked on molecular biology research at the National Institutes of Health, the Weizmann Institute of Science, Yale University, and the University of California San Diego. Wojcicki was a competitive ice skater and played varsity ice hockey while at Yale.

Anne Wojcicki is an investor, biologist, businesswoman, philanthropist, and the co-founder and CEO of 23andMe. She also serves on the board of 23andMe, the board of Breakthrough Prize, cofounded the Brin Wojcicki Foundation, and founded the Anne Wojcicki Foundation. In 2021, Wojcicki was ranked #25 in Forbes' America's Self-Made Women and #90 in the Forbes' Power Women, and her net worth was estimated at $1.1 billion. Additionally, she is the younger sister of Susan Wojcicki, CEO of YouTube, and was married to Sergey Brin, the co-founder of Google.

In 2021, Wojcicki was ranked #25 in Forbes' America's Self-Made Women and #90 in the Forbes' Power Women, and her net worth was estimated at $1.1 billion. Additionally, she is the younger sister of Susan Wojcicki, CEO of YouTube, and was married to Sergey Brin, the co-founder of Google.

Anne Wojcicki, Co-founder and CEO of 23andMe

Wojcicki co-founded 23andMe in 2006 along with Linda Avey and Paul Cusenza. Anne is a pioneer in the direct-to-consumer DNA testing space and her vision and persistence have allowed 23andMe to provide people with unprecedented access to genetic information. Through its research platform, 23andMe has brought personalized medicine directly to millions of consumers.She hoped to empower consumers with access to their own genetic information and to create a way to generate more personalized information so that commercial and academic researchers could better understand and develop new drugs and diagnostics. Getting access to and understanding her own genetic information had always been one of her ambitions.

Wojcicki co-founded 23andMe in 2006 with Linda Avey and Paul Cusenza. Before founding 23andMe, Wojcicki spent ten years on Wall Street investing in healthcare. During her time there, she felt frustrated by a system built around monetizing illness instead of incentivizing prevention. She wanted to build a business that would help people prevent illness rather than profit from it.

Before founding 23andMe, Wojcicki spent ten years on Wall Street investing in healthcare and felt frustrated by a system built around monetizing illness instead of incentivizing prevention. She wanted to build a business that helps people prevent illness rather than profit from it. Anne focused on empowering people with direct access to genetic information so that they could use their data to make decisions that could lower their risks for disease. Under her leadership, 23andMe now provides the only personal genetic test with FDA authorization to deliver health information directly to consumers.

Additionally, getting access to and understanding her own genetic information had always been one of her ambitions. Wojcicki started 23andMe with the hope to empower others with access to their own genetic information and to create a way to generate more personalized information so that commercial and academic researchers could better understand and develop new drugs and diagnostics.

23andMe has built one of the world’s largest databases of individual genetic information. Its novel, web-based research approach allows for the rapid recruitment of participants to many genome-wide association studies at once, reducing the time and money needed to make new discoveries. The company has also created a proven and standardized resource for finding new genetic associations and confirming genetic loci discovered by others. Under Wojcicki’s leadership, 23andMe has made significant advances in bringing personalized medicine directly to the public.

23andMe provides the only personal genetic test with FDA authorization to deliver health information directly to consumers. The company has brought personalized medicine directly to millions of consumers, and Wojcicki is considered a pioneer in the direct-to-consumer DNA testing industry.

Anne Wojcicki is an investor, biologist, businesswoman, philanthropist, and the co-founder and CEO of 23andMe. She also serves on the board of 23andMe, the board of Breakthrough Prize, cofounded the Brin Wojcicki Foundation, and founded the Anne Wojcicki Foundation. In 2021, Wojcicki was ranked #25 in Forbes' America's Self-Made Women and #90 in the Forbes' Power Women, and her net worth was estimated at $1.1 billion. Additionally, she is the younger sister of Susan Wojcicki, CEO of YouTube, and was married to Sergey Brin, the co-founder of Google.

Wojcicki earned a BS in Biology from Yale University in 1996. She also worked on molecular biology research at the National Institutes of Health, the Weizmann Institute of Science, Yale University, and the University of California San Diego. Wojcicki was a competitive ice skater and played varsity ice hockey while at Yale.

Anne Wojcicki is an investor, biologist, businesswoman, philanthropist, and the co-founder and CEO of 23andMe. She also serves on the board of 23andMe, the board of Breakthrough Prize, cofounded the Brin Wojcicki Foundation, and founded the Anne Wojcicki Foundation. In 2021, Wojcicki was ranked #25 in Forbes' America's Self-Made Women and #90 in the Forbes' Power Women, and her net worth was estimated at $1.1 billion.

Prior toBefore founding 23andMe, Wojcicki spent ten years on Wall Street investing in healthcare and felt frustrated by a system built around monetizing illness instead of incentivizing prevention. She wanted to build a business that helps people prevent illness rather than profit from it. Anne focused on empowering people with direct access to genetic information so that they could use their data to make decisions that could lower their risks for disease. Under her leadership, 23andMe now provides the only personal genetic test with FDA authorization to deliver health information directly to consumers.

Anne Wojcicki is an investor, biologist, businesswoman, philanthropist, and the co-founder and CEO of 23andMe. She also serves on the board of 23andMe, the board of Breakthrough Prize, cofounded the Brin Wojcicki Foundation, and founded the Anne Wojcicki Foundation.

Wojcicki co-founded 23andMe in 2006 along with Linda Avey and Paul Cusenza. SheAnne is a pioneer in the direct-to-consumer DNA testing space and her vision and persistence have allowed 23andMe to provide people with unprecedented access to genetic information. Through its research platform, 23andMe has brought personalized medicine directly to millions of consumers.She hoped to empower consumers with access to their own genetic information and to create a way to generate more personalized information so that commercial and academic researchers could better understand and develop new drugs and diagnostics. Getting access to and understanding her own genetic information had always been one of her ambitions.

Prior to founding 23andMe, Wojcicki spent ten years on Wall Street investing in healthcare and felt frustrated by a system built around monetizing illness instead of incentivizing prevention. She wanted to build a business that helps people prevent illness rather than profit from it. Anne focused on empowering people with direct access to genetic information so that they could use their data to make decisions that could lower their risks for disease. Under her leadership, 23andMe now provides the only personal genetic test with FDA authorization to deliver health information directly to consumers.

Wojcicki earned a BS in Biology from Yale University in 1996.

Wojcicki earned a BS in Biology from Yale University in 1996. She also worked on molecular biology research at the National Institutes of Health, the Weizmann Institute of Science, Yale University, and the University of California San Diego.

Wojcicki co-founded 23andMe in 2006 along with Linda Avey and Paul Cusenza. She hoped to empower consumers with access to their own genetic information and to create a way to generate more personalized information so that commercial and academic researchers could better understand and develop new drugs and diagnostics. Getting access to and understanding her own genetic information had always been one of her ambitions.

Anne Wojcicki is an investor, biologist, businesswoman, and the co-founder and CEO of 23andMe.

Wojcicki co-founded 23andMe in 2006. She hoped to empower consumers with access to their own genetic information and to create a way to generate more personalized information so that commercial and academic researchers could better understand and develop new drugs and diagnostics. Getting access to and understanding her own genetic information had always been one of her ambitions.

23andMe has built one of the world’s largest databases of individual genetic information. Its novel, web-based research approach allows for the rapid recruitment of participants to many genome-wide association studies at once, reducing the time and money needed to make new discoveries. The company has also created a proven and standardized resource for finding new genetic associations and confirming genetic loci discovered by others. Under Wojcicki’s leadership, 23andMe has made significant advances in bringing personalized medicine directly to the public.

Wojcicki earned a BS in Biology from Yale University in 1996.